Arvato Supply Chain Solutions offers storage capabilities for cell & gene therapies
Gütersloh (a), Arvato Supply Chain Solutions, a leading supply chain service provider and among others market leader in Europe for integrated order-to-cash solutions for the Healthcare industry, in collaboration with Brooks Life Sciences, global supplier of complete automation solutions for the life sciences industry, is expanding and automating warehousing for Advanced Therapies such as cell and gene therapies, that require ultra-low or cryogenic temperature environments.
Advanced therapies are therapeutic procedures to treat serious and often rare diseases more effectively. The aim is to replace malfunctioning or defective cells or to initiate processes for regeneration. These novel therapies, however, implicate unique requirements regarding storage and logistics that are difficult for healthcare manufacturers to manage. “Arvato has therefore decided to expand its European storage and warehousing capacities in cooperation with Brooks Life Sciences in Germany to offer customers best-in-class automated ultracold storage services including LN2 cryogenic storage,” explains Dr. Thorsten Winkelmann, President Healthcare.
For Arvato’s customers, this means that in addition to established international service offerings for commercial distribution they now also benefit from Brooks Life Sciences deep application experience and proven technologies to protect sample integrity while adding precise inventory accuracy and documentation. Sample quality and simultaneous compliance with regulatory requirements is assured by Brooks’ team of ultra-low storage experts. Dr. Markus Albertini, Director of Brooks Life Sciences European Services: “Arvato customers have access to our complete sample management and biorepository services, including the Brooks Life Sciences BioStore™ III automated storage system, to provide secure and accurate inventory control, optimized customer workflows, and improved sample throughput. The system provides a flexible, modular, and automated solution for a wide range of labware and can be used for materials requiring storage at temperatures between -20°C and -196°C.”
The comprehensive network of Arvato Supply Chain Solutions' Healthcare business unit currently comprises 17 international sites with a total storage area of 200,000 square meters. Temperature controlled areas allow storage of sensitive products from an ultra-low or cryogenic environment (-196°C) up to ambient (+15°C to +25°C).
The individual logistics centers are equipped with state-of-the-art infrastructure, certified according to GMP, GDP, IATA and ISO and meet the requirements of modern temperature-controlled supply chain management in all temperature classes. This network is currently to be enriched to meet the special requests of cell and gene therapies.
Arvato´s mission is to deliver high value to the healthcare industry by managing the complexity of advanced therapies through digital technology and operational services. Dr. Thorsten Winkelmann: “By creating an opportunity for cell and gene therapy manufacturers to store their sophisticated products professionally, they can also benefit from Arvato's complete range of order-to-cash logistics services out of one hand. In addition to storage and distribution, we also provide customer and financial services. Thus our customers benefit from an integrated end-to-end solution.”
About Arvato Supply Chain Solutions:
Arvato Supply Chain Solutions is an innovative and international leading service provider in the field of supply chain management and e-commerce. Partners come together with industry specialists in the fields of Healthcare, Telecommunication, Hightech, Entertainment, Corporate Information Management, Healthcare, Consumer Products and Publisher. About 15,000 employees work together to provide practical and relevant solutions and services worldwide. Using the latest digital technology, Arvato develops, operates, and optimizes complex global supply chains and e-commerce platforms, as the strategic growth partner for its customers. Arvato combines the know-how of its employees with the right technology and appropriate business processes to measurably increase the productivity and performance of its partners.
For more information, please visit www.arvato-supply-chain.com.
Arvato Supply Chain Solutions is part of Arvato, a leading international service provider. More than 70,000 employees in almost 40 countries develop and implement innovative solutions for business customers all over the world. These include SCM and IT solutions as well as financial and customer communication services, which are continuously developed with a focus on innovations in automation and data/analytics.
Globally renowned companies from a wide variety of industries – from telecommunications providers and energy providers to banks and insurance companies, e-commerce, IT, and Internet providers – rely on Arvato’s portfolio of solutions.
Arvato is a division of Bertelsmann.
Arvato’s Healthcare business
We believe that healthcare systems, sales channels and distribution chains undergo constant change to ensure patients derive the greatest benefit from innovative and existing pharmaceuticals and medical products at the most reasonable costs. We support you in making this happen! Arvato integrates healthcare know-how, industry knowledge and broad understanding of processes and IT systems to develop bespoke outsourcing solutions.
Our clients benefit from seamlessly integrated order-to-cash solutions, which connect them to the point of care, bringing them closer to their patients.
More information is available at https://arvato-supply-chain.com/en/industry-solutions/healthcare/cell-gene-therapy
About Brooks Life Sciences
Brooks Life Sciences is a leading provider of life science sample-based solutions. As a service provider to labs around the world, Brooks Life Sciences offers a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research, and advanced cell therapies for the industry's top pharmaceutical, biotech, academic, and healthcare institutions globally. Brooks Life Sciences' GENEWIZ division is a leading provider of DNA gene sequencing and gene synthesis services. The organization is headquartered in Chelmsford, MA, with operations in North America, Europe, and Asia.
For more information visit www.brookslifesciences.com.